Comprehensive use of cardi- opulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125:250 9. S2.2-17. M ller J, Hager A, Diller G-P, et al. Peak oxygen uptake, venti- latory efficiency and QRS-duration predict event free survival in patients late after surgical repair of tetralogy of Fallot. Int J Cardiol. 2015;196:158 64. S2.2-18. Kempny A, Dimopoulos K, Uebing A, et al. Reference values for exer- cise limitations among adults with congenital heart disease. Relation to activities of daily life single centre experience and review of pub- lished data. Eur Heart J. 2012;33:1386 96. S2.2-19. New York Heart Association. Dolgin M. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, MA: Little, Brown and Co, 1994. S2.2-20. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D42 50. 2.3. The ACHD AP Classification S2.3-1. Verheugt CL, Uiterwaal CSPM, van der Velde ET, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31:1220 9. S2.3-2. Diller G-P, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828 35. S2.3-3. Dimopoulos K, Diller G-P, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320 8. S2.3-4. Dimopoulos K, Okonko DO, Diller G-P, et al. Abnormal venti- latory response to exercise in adults with congenital heart di- sease relates to cyanosis and predicts survival. Circulation. 2006;113:2796 802. S2.3-5. Hebson CL, McCabe NM, Elder RW, et al. Hemodynamic pheno- type of the failing Fontan in an adult population. Am J Cardiol. 2013;112:1943 7. S2.3-6. Khairy P, Aboulhosn J, Gurvitz MZ, et al. 